Botulinum Toxin Injections
J15
38 active Medicare policies list G43.001, and 25 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
25 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 16 · All Aetna policies
| Policy | Effective | Status of G43.001 |
|---|---|---|
| Acupuncture and Dry Needling | Apr 5, 2023 | Covered |
| Attended Electroencephalographic (EEG) Video Monitoring | Apr 28, 2023 | Covered |
| Botulinum Toxin | Jan 1, 2024 | Covered |
| Chiropractic Services | Mar 23, 2023 | Covered |
| Headaches: Invasive Procedures | Feb 20, 2024 | Covered |
| Headaches: Nonsurgical Management | Feb 16, 2024 |
J5
J8 · Effective Feb 22, 2026
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Oct 1, 2025
J5 · Effective Oct 1, 2025
| Histamine Desensitization Therapy for Intractable Headaches | Sep 13, 2023 | Covered |
|---|
| Homocysteine Testing | Oct 26, 2023 | Covered |
|---|
| Infrared Therapy | Sep 8, 2023 | Covered |
|---|
| Intra-oral Appliances for Headaches and Trigeminal Neuralgia | Dec 13, 2023 | Covered |
|---|
| Policy | Effective | Status of G43.001 |
|---|---|---|
| Balloon Sinus Ostial Dilation | Jul 1, 2026 | Covered |
| Biofeedback and Neurofeedback | Jul 1, 2026 | Covered |
| Implantation of Occipital, Supraorbital or Trigeminal Nerve Stimulation Devices (and Related Procedures) | Oct 1, 2026 | Not covered |
| Occipital and Sphenopalatine Ganglion Nerve Block Therapy for the Treatment of Headache and Neuralgia | Oct 1, 2026 | Not covered |
| Surface Electrical Stimulation Devices for Headache and Migraine | Apr 15, 2026 | Covered |
| Surgical and Ablative Treatments for Chronic Headaches | Apr 15, 2026 | Not covered |
| Policy | Effective | Status of G43.001 |
|---|---|---|
| Visual Field Testing | Not recorded | Covered |
| Policy | Effective | Status of G43.001 |
|---|---|---|
| Peripheral Nerve Destruction for Pain Conditions | Sep 15, 2026 | Not covered |
| Policy | Effective | Status of G43.001 |
|---|---|---|
| Vyepti (Eptinezumab-Jjmr) | Sep 1, 2026 | Covered |